Comments to FDA: Gingivitis Drugs for Treatment or Prevention

The following comments are submitted by the Joint Oral Care Task Group CHPA and the Cosmetic, Toiletry, and Fragrance Association with respect to the Draft Guidance for Industry on Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention.